Norman Baylor
Norman Baylor is a former director of the FDA’s Office of Vaccine Research and Review, known for his expertise in vaccine policy and regulation. He has been vocal about the importance of the FDA's advisory committees, particularly in making critical decisions regarding vaccine strain selection, as seen in recent discussions surrounding the cancellation of key meetings related to the upcoming flu vaccine season.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| India | 1 | 5.00 | 0.02% | +0% | 1,380,004,385 | 244,205 | $2,900,000 | 513$ |
| Totals | 1 | 1,380,004,385 | 244,205 | $2,900,000 | 513$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
India:
Norman Baylor, a former director of the FDA’s Office of Vaccine Research and Review, expressed shock at the cancellation of the VRBPAC meeting.
5